Mark N. Levine
Impact in
- Internal Medicine top 0.01%
- Venous Thromboembolism Diagnosis and Management
- Emergency Medical Services top 0.01%
- Central Venous Catheters and Hemodialysis
Papers in
-
- Venous Thromboembolism Diagnosis and Management 75
- Oncology 76
- Cancer Treatment and Pharmacology 18
- Cancer survivorship and care 15
- Co-authors
- Michael Gent (16 shared papers)A. Lee (10 shared papers)Jim A. Julian (40 shared papers)Ajay K. Kakkar (12 shared papers)Jack Hirsh (12 shared papers)Clive Kearon (5 shared papers)Frederick R. Rickles (8 shared papers)Timothy Joseph Whelan (42 shared papers)
- Journals
- Journal of Clinical Oncology (62 papers)CHEST Journal (10 papers)Breast Cancer Research and Treatment (10 papers)Thrombosis and Haemostasis (9 papers)New England Journal of Medicine (8 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Mark N. Levine
292 papers receiving 31.8k citations
Mark N. Levine's Hit Papers
Peers
Comparison fields: 5 of 194
- Internal Medicine 11.6k
- Emergency Medical Services 2.7k
- Cardiology and Cardiovascular Medicine 7.0k
- Hematology 3.5k
- Cancer Research 3.7k
Countries citing papers authored by Mark N. Levine
This map shows the geographic impact of Mark N. Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark N. Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark N. Levine more than expected).
Fields of papers citing papers by Mark N. Levine
This network shows the impact of papers produced by Mark N. Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark N. Levine. The network helps show where Mark N. Levine may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark N. Levine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 304 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer Hit paper breakdown → | 2003 | 1964 |
| 2 | Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin Hit paper breakdown → | 1995 | 1891 |
| 3 | Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer Hit paper breakdown → | 2010 | 1401 |
| 4 | Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Hit paper breakdown → | 1996 | 1093 |
| 5 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update Hit paper breakdown → | 2019 | 1032 |
| 6 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014 Hit paper breakdown → | 2015 | 1020 |
| 7 | Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) Hit paper breakdown → | 2018 | 956 |
| 8 | Hemorrhagic Complications of Anticoagulant Treatment Hit paper breakdown → | 2001 | 810 |
| 9 | American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer Hit paper breakdown → | 2007 | 762 |
| 10 | Venous Thromboembolism and Cancer: Risks and Outcomes Hit paper breakdown → | 2003 | 586 |
| 11 | Vitamin C: the known and the unknown and Goldilocks Hit paper breakdown → | 2016 | 583 |
| 12 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2013 | 582 |
| 13 | Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment Hit paper breakdown → | 2008 | 553 |
| 14 | 2004 | 536 | |
| 15 | Influence of Cigarette Smoking on the Efficacy of Radiation Therapy in Head and Neck Cancer Hit paper breakdown → | 1993 | 492 |
| 16 | 1998 | 477 | |
| 17 | 2006 | 423 | |
| 18 | 1994 | 421 | |
| 19 | 1989 | 412 | |
| 20 | 1997 | 412 |
About Mark N. Levine
Mark N. Levine is a scholar working on Internal Medicine, Oncology, Cancer Research, Cardiology and Cardiovascular Medicine and Emergency Medical Services, having authored 304 papers that have together received 33.7k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (75 papers), Breast Cancer Treatment Studies (43 papers), Atrial Fibrillation Management and Outcomes (21 papers), Vitamin C and Antioxidants Research (20 papers), Cancer Treatment and Pharmacology (18 papers), Central Venous Catheters and Hemodialysis (16 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers) and Cancer survivorship and care (15 papers). The work is most often cited by research in Internal Medicine (11.6k citations), Emergency Medical Services (2.7k citations), Cardiology and Cardiovascular Medicine (7.0k citations), Hematology (3.5k citations) and Cancer Research (3.7k citations). Mark N. Levine has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Michael Gent, A. Lee, Jim A. Julian, Ajay K. Kakkar, Jack Hirsh, Clive Kearon, Frederick R. Rickles, Timothy Joseph Whelan, K. Pritchard and Gary E. Raskob. Their work appears in journals such as Journal of Clinical Oncology, CHEST Journal, Breast Cancer Research and Treatment, Thrombosis and Haemostasis and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.